Biomarkers: A Way Forward with Prostate Cancer Early Detection
Dr. E. David Crawford presented “Biomarkers: A Way Forward with Prostate Cancer Early...
Read More
Perspectives in Urology: Point-Counterpoint
Prostate Cancer: Why the Controversy?
Dr. Michael S. Cookson, MD, MMHC, provides an update on the latest AUA recommendations and touches on some of the controversy around the 2012 changes for treating prostate cancer, and what happened thereafter.
Read More
How to Differentiate the Causes of Lower Urinary Tract Symptoms
Dr. Matt T. Rosenberg, MD discusses the Causes of Lower Urinary Tract Symptoms, Flow vs. Volume, and When to diagnose BPH vs. OAB.
Read More
Association of BPH with OAB: The Plumbing or the Pump?
Dr. Ryan P. Terlecki, MD, FACS, discusses concomitant treatments of overactive bladder and BPH, properly diagnosing sources of LUTS, and when it is appropriate to order urodynamics for a patient.
Read More
Testosterone Therapy, the FDA, and CVD Risk Controversies
Dr. Matt T. Rosenberg, MD, argues both sides of the testosterone therapy controversy. He explains how supplementing testosterone in men with testosterone deficiency can be beneficial, but also risky from a cardiovascular standpoint.
Read More